Pharma channel feed

Drug­mak­ers gear up for joint IRA ar­gu­ments as PhRMA ap­peals Texas ver­dict

Last year
Law

Sun Phar­ma re-en­lists pop­u­lar ‘Pim­ple Pop­per’ doc­tor for ac­ne brand TV cam­paign

Last year
Marketing

FDA sees suc­cess in mod­el-in­formed drug de­vel­op­ment pi­lot

Last year
FDA+

Tar­sus’ eye drops in­ter­rupt an an­i­mat­ed mite 'par­ty’ in first DTC ad for Xdemvy

Last year
Marketing

Val­isure pres­sures FDA to re­call ac­ne treat­ments af­ter find­ing car­cino­gen

Last year
FDA+

FDA faces flat­lined bud­get as clock ticks for Con­gress to pass gov­ern­ment fund­ing

Last year
FDA+

Sen­ate com­mit­tee ad­vances bill tar­get­ing Chi­nese man­u­fac­tur­ers as BIO faces at­tack for back­ing WuXi

Last year
China
Manufacturing

Sen. War­ren at­tacks GSK's de­ci­sion to shift in­haler from brand to au­tho­rized gener­ic

Last year
Law

Eu­ro­pean Com­mis­sion spells out new pro­pos­als for health tech­nol­o­gy as­sess­ments

Last year
FDA+

Pfiz­er says IRA im­pact will be 'mod­est,' maps out R&D pri­or­i­ty changes

Last year

San­doz wins FDA ap­proval for first two biosim­i­lars for Am­gen's block­buster bone drug

Last year
FDA+

UK's NICE rec­om­mends against cov­er­age for As­traZeneca and Dai­ichi's breast can­cer drug En­her­tu over cost-ef­fec­tive­ness

Last year

J&J ex­pands myelo­ma and health eq­ui­ty ef­forts with fe­male hip-hop pi­o­neer MC Lyte

Last year
Marketing

Mar­ket­ingRx roundup: Pfiz­er jumps on lat­est Tik­Tok trend; No­vo re­cruits for Ca­griSe­ma tri­al across lan­guages

Last year
Marketing

FDA de­nies hear­ing to Van­da on jet lag in­di­ca­tion for sleep dis­or­der drug

Last year
FDA+

Amy­lyx read­ies for make-or-break PhI­II, look­ing to ad­dress un­cer­tain­ty over con­tro­ver­sial ALS drug

Last year
R&D
In Focus

Bay­er on job cuts, pipeline gaps, obe­si­ty and Mon­san­to lit­i­ga­tion as ex­ecs de­fend keep­ing cur­rent struc­ture

Last year
R&D

Bay­er says no breakup ‘for now,’ fo­cus­es in­stead on fix­ing ‘bad­ly bro­ken’ ar­eas 

Last year

Re­pub­li­can sen­a­tors join at­tack on Biden's pro­pos­al to seize drug patents based on price

Last year
Law

FTC's Lina Khan and Mark Cuban head­line White House lis­ten­ing ses­sion to rail against PBMs

Last year

Hugel smooths out wrin­kles with FDA, wins ap­proval for Botox com­peti­tor

Last year
FDA+

San­doz com­pletes $170M buy of Lu­cen­tis biosim­i­lar from Co­herus Bio­Sciences

Last year
Deals

Q&A: Sanofi’s CEO on the con­sumer di­vesti­ture, a fu­ture in weight loss, an­titrust and AI’s se­cre­cy wave

Last year

Bay­er buys Eu­ro­pean rights to Bridge­Bio's AT­TR-CM pill

Last year
Deals
First page Previous page 69707172737475 Next page Last page
A service from the Financial Times